ZENTRUDO Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for ZENTRUDO with the United States Patent and Trademark Office. The USPTO has given the ZENTRUDO trademark a serial number of 98440296. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 5, 2024. This trademark is owned by Teva Pharmaceuticals International GmbH. The ZENTRUDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the skin, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations f...
zentrudo

General Information


Serial Number98440296
Word MarkZENTRUDO
Filing DateFriday, March 8, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the skin, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals International GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressJona 8645
CH

Party NameTeva Pharmaceuticals International GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJona 8645
CH

Trademark Events


Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Friday, March 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2024ASSIGNED TO EXAMINER
Tuesday, September 24, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 24, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 24, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, September 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 5, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED